Web28 Jan 2024 · The net proceeds to Seelos from this offering are expected to be approximately $33.5 million, after deducting underwriting discounts and commissions … Web9 Aug 2024 · Seelos Business Update As of the end of Q2, Seelos had $87 .2mm of cash. It currently has no outstanding debt. In January, Seelos raised $33.5 million in net proceeds in an offering of...
Seelos Therapeutics Announces Registered Direct Offering of …
Web24 May 2024 · Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares. Guggenheim … Web10 Mar 2024 · Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock - Seelos Therapeutics (NASDAQ:SEEL) - Benzinga rbg family membership
Seelos Therapeutics (SEEL) Prices $60 Million Public Offering of …
Web23 Dec 2024 · On May 12, 2024, Seelos Therapeutics, Inc. (the "Company") entered into an Open Market Sale AgreementSM (the "Sale Agreement") with Jefferies LLC, as sales agent (the "Agent"), pursuant to which the Company may offer and sell shares of its common stock, par value $0.001 per share (the "Shares"), from time to time, through the Agent (the … Web13 Apr 2024 · Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company’s lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and … Web10 Mar 2024 · NEW YORK, March 10, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous ... rbg family health